A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer

Demirkol, Secil; Gomceli, Ismail; Isbilen, Murat; Dayanc, Baris; Tez, Mesut; Bostanci, Erdal; Turhan, Nesrin; Akoglu, Musa; Ozyerli, Ezgi; Durdu, Sevi; Konu, Ozlen; Nissan, Aviram; Gonen, Mithat; Gure, ALİ

doi:10.7150/jca.17872

A Combined ULBP2 and SEMA5A Expression Signature as a Prognostic and Predictive Biomarker for Colon Cancer

Atıf İçin Kopyala

Demirkol S., Gomceli I., Isbilen M., Dayanc B. E. , Tez M., Bostanci E. B. , ...Daha Fazla

JOURNAL OF CANCER, cilt.8, sa.7, ss.1113-1122, 2017 (SCI İndekslerine Giren Dergi)

Cilt numarası: 8 Konu: 7
Basım Tarihi: 2017
Doi Numarası: 10.7150/jca.17872
Dergi Adı: JOURNAL OF CANCER
Sayfa Sayıları: ss.1113-1122

Özet

Background: Prognostic biomarkers for cancer have the power to change the course of disease if they add value beyond known prognostic factors, if they can help shape treatment protocols, and if they are reliable. The aim of this study was to identify such biomarkers for colon cancer and to understand the molecular mechanisms leading to prognostic stratifications based on these biomarkers.